Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021
17. August 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
Yield10 Bioscience Announces Second Quarter 2020 Financial Results
11. August 2020 16:05 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and six months ended June...
Yield10 Bioscience Announces First Quarter 2020 Financial Results
14. Mai 2020 16:15 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three months ended March 31,...
Yield10 Bioscience Secures Regulatory Permits for U.S. and Canadian Sites and Announces Plans for 2020 Field Test Program in Camelina and Canola
14. Mai 2020 16:10 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 14, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that the Company has secured all of the regulatory permits...
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulatory Status of its CRISPR Genome-Edited C3007 Trait in Camelina, Paving the Way for U.S. Field Tests
27. April 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results
19. März 2020 16:04 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today reported financial results for the three and twelve months ended...
Yield10 Bioscience Announces Results of 2019 Field Test Program
19. März 2020 16:02 ET
|
Yield10 Bioscience, Inc.
-- 2019 Field Test Results Highlight CRISPR Technology Approach to Increase in Oil Content in Oilseed Crops -- Outlines Field Tests Planned for 2020 WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE)...
Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests
16. Januar 2020 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Signs Exclusive Worldwide License with University of Missouri for Advanced Technology Used to Boost Oil Content in Crops
08. Mai 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the...
Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content
02. Oktober 2018 08:00 ET
|
Yield10 Bioscience, Inc.
--USDA-APHIS Response Marks Clearance of Yield10’s First Triple Genome-edited Plant Lines --Favorable Response Accelerates Path to U.S. Field Trials in 2019 WOBURN, Mass., Oct. 02, 2018 (GLOBE...